Concepedia

Lei Nie

LN

38

Publications

2.7K

Citations

27

H-Index

2002

Active since

Affiliations

Center for Drug Evaluation and Research(Current)

United States Food and Drug Administration

Georgetown University

The University of Texas MD Anderson Cancer Center

University of North Carolina at Chapel Hill

Lei Nie is an author at Center for Drug Evaluation and Research specializing in statistics, biostatistics, and medicine.

ORCID

Top concepts

Publications per year

2002–2023

38

Publications

38

FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome

Robert Q. Le, Liang Li, Weishi Yuan et al. · The Oncologist · 2018 · 859 citations · Full text

FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic Leukemia

R. Angelo de Claro, Karen M. McGinn, Nicole Verdun et al. · Clinical Cancer Research · 2015 · 156 citations

, , +18

FDA Approval Summary: Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease

Donna Przepiorka, Lola Luo, Sriram Subramaniam et al. · The Oncologist · 2019 · 129 citations · Full text

, , +17

Network meta-analysis of randomized clinical trials: Reporting the proper summaries

Jing Zhang, Bradley P. Carlin, James D. Neaton et al. · Clinical Trials · 2013 · 124 citations · Full text

Time-to-Event Bayesian Optimal Interval Design to Accelerate Phase I Trials

Ying Yuan, Ruitao Lin, Daniel Li et al. · Clinical Cancer Research · 2018 · 122 citations · Full text

Rows per page

1–5 of 38